A survey conducted by the National Community Pharmacists Association (NCPA) revealed that almost all independent pharmacies experience significant increase in drug acquisition cost while reimbursements are not simultaneously adjusted to reflect the increase. Often, reimbursements are adjusted but with remarkable delays. When pharmacies appeal these MAC reimbursements and delays in adjusting generic pricing, the appeals
Avoiding iabilities when measuring blood-glucose
This month, I will be presenting a series of webinars organized by Nova Biomedical aimed to educate healthcare practitioners on what constitutes off-label use of blood-glucose meters (BGM). My part of the presentation will focus on the risks associated with the off-label use of BMGs and the ways to avoid potential liabilities.
Why did
10 Complimentary Passes to a Webinar on Controlled Substances
Please join me for a live webinar, “Opioids and Other Controlled Substances: Minimizing the Risks in Prescribing, Dispensing and Administering” scheduled for Wednesday, April 17, 1:00pm-2:30pm EDT.
I will be speaking on new regulations and practices pertaining to TeleHealth and e-prescribing. My co-speakers include: Kerry B. Harvey, Member at Dickinson Wright; Lindsay P. Holmes
You are invited! A webinar on prescribing, dispensing and administering controlled substances
I am pleased to announce that I will be speaking in an upcoming Strafford live webinar, “Opioids and Other Controlled Substances: Minimizing the Risks in Prescribing, Dispensing and Administering” scheduled for Wednesday, April 17, 1:00pm-2:30pm EDT.
Because of your affiliation with my firm, you are eligible to attend this program at half off. As
You are Invited: Pharmacy Law Conference
Natalia will be speaking at the largest pharmacy law conference organized by the American Society for Pharmacy Law. The subject of her talk is “Your Pharmacy is Being Audited by DEA – Complying, Defending, and Prevailing!” Natalia will focus on:
– differences between DEA’s administrative actions and criminal prosecution;
– how to avoid the case
You are invited to a webinar: “Prescription Audits: When the DEA or AG Come Knocking”
I am pleased to announce that I will be speaking in an upcoming Strafford live webinar, “Prescription Audits: When the DEA or AG Come Knocking” scheduled for Wednesday, August 22, 1:00pm-2:30pm EDT.
The Drug Enforcement Administration (DEA) and state attorneys general (AGs) are increasing scrutiny on medical providers at all levels who are involved in
Webinar on DEA Enforcement and Update on Working with Controlled Substances
If you are working with controlled substances, it’s imperative to stay abreast of the developments in the DEA enforcement, as well as of any updates and changes in the arena. I will be teaching a webinar with the DEA and William Keane on December 12.
Overview of the webinar:
The webinar will review the recent
Join me at the American Bar Association (ABA) Health Law conference!
I will be discussing hot topics in controlled substances prescribing, administering, and dispensing at the next ABA Health Law conference on June 8th in Chicago. A DEA’s special agent in charge will join me and will describe new trends in DEA’s audits, registration, and explain some red flags that can put you on the DEA’s
APhA annual conference and what’s in store for independent pharmacies
Yesterday I attended the biggest pharmacy conference I’ve ever been to – APhA’s annual conference with around 6,000 attendees. This year it happened to be in my home city, San Francisco, and I decided to take advantage and do a short presentation on the PBM updates during the Pharmacy Planning Services’ (PPSI) breakfast. In a